COMMUNIQUÉS West-GlobeNewswire

Terumo Neuro Announces Two WISE Study Publications Reporting 0% New Bleeds or Rebleeds Through One Year Following WEB™ Treatment in Ruptured and Unruptured Aneurysm Cohorts
31/08/2026
Findings from the largest prospective WEB pooled dataset strengthen the clinical evidence supporting WEB treatment across distinct ruptured and unruptured aneurysm cohorts. Aliso Viejo, CA, Aug. 31, 2026 (GLOBE NEWSWIRE [...]
Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
31/08/2026
Company announcement No. 44 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 35, 2026) Copenhagen, Denmark, August 31, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
Kegel Care Launches Personalized Pelvic Floor Training App for Women
31/08/2026
New Kegel Care App Turns a Short Quiz Into a Guided Kegel Plan NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Kegel Care has launched a pelvic health and wellness app built around personalized Kegel exercises for women. [...]
"Traverser la séparation" Launches a Specialized Psychotherapy Program for Adults Facing a Painful Breakup
31/08/2026
Confronting a form of suffering that is still too often downplayed, the practice founded by psychotherapist Gérald Bovet offers a structured eight-week framework — online and in person — combining a psychoanalytic [...]
Physician Health Programs Need Reform, according to the Journal of American Physicians and Surgeons
31/08/2026
TUCSON, Ariz., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Although Physicians Health Programs (PHPs) are purportedly for helping impaired physicians recover and return to practice, the only thing that may be missing from the [...]
Physicians Need to Fight for the Cause of America, Writes President of the Association of American Physicians and Surgeons (AAPS)
31/08/2026
TUCSON, Ariz., Aug. 31, 2026 (GLOBE NEWSWIRE) -- On the 250 th anniversary of our Declaration of Independence, the need for physicians to fight for the Cause of America is increasingly urgent, writes George L. Smith , [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 35 - 2026
31/08/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 24th August to 28th August 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial [...]
New genomics collaboration to enable First Nations sovereignty over salmon data
31/08/2026
VANCOUVER, British Columbia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- A new multi-year, multi-partner collaboration aims to empower First Nations communities in British Columbia with salmon genetic analysis tools, technology, [...]
Coherus to Participate in Upcoming Investor Conferences
31/08/2026
REDWOOD CITY, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS), today announced that the company will be participating in upcoming investor conferences: Baird 2026 Global Healthcare [...]
ProSomnus Prevails in Intellectual Property Enforcement Action
31/08/2026
Federal Court Awards Damages, Fees and Costs Following ProSomnus Intellectual Property Enforcement Action SAN FRANCISCO, Aug. 31, 2026 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies (“ProSomnus”), the pioneer and [...]
Persevere Therapeutics Announces Appointment of James Barlow to Board of Directors
31/08/2026
Chesterbrook, PA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Persevere Therapeutics, Inc. (“Persevere”), a clinical-stage oncology company developing misetionamide — a first-in-class inhibitor of MYC, historically viewed as [...]
SEMCAP Beauty & Wellness Leads Funding Round For Healf
31/08/2026
SEMCAP Beauty & Wellness leads investment in Healf, the personalized wellbeing platform helping consumers make more confident decisions about their health. Healf combines expert curation, diagnostics, wearable [...]
AIM ImmunoTech Secures Broad U.S. Patent for Rintatolimod (Ampligen®) Used in Combination with Pembrolizumab (Keytruda®), Expanding Oncology IP Protection for Ampligen Through 2039
31/08/2026
Patent covers synergistic use of Ampligen with pembrolizumab across cancer indications, including pancreatic, ovarian, colorectal, breast, lung and other cancers, reinforcing the potential breadth and long-term value of [...]
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
31/08/2026
Berkeley, CA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA) (the “Company”) announced that it has received a letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market [...]
Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth
31/08/2026
New NIH award will provide approximately $908,000 in year-long support of preclinical development, with potential for an additional future-year grant of approximately $1.3 million DARE-PTB2 is an early-stage, [...]
OneMedNet’s iRWD Platform Enables Rapid Feasibility-to-Delivery for Leading AI-Driven Drug Development Company
31/08/2026
Customer selects OneMedNet for the full-fidelity studies and regulatory decision-grade quality required to develop AI models that accelerate drug development MINNEAPOLIS, Aug. 31, 2026 (GLOBE NEWSWIRE) -- OneMedNet [...]
Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD
31/08/2026
Chloe Kim is partnering with Supernus to highlight the importance of recognizing ADHD in adults and help empower individuals to work with their doctors to develop a tailored treatment plan. While ADHD is often [...]
Lexicon Announces New Post Hoc SOLOIST-WHF Analysis Demonstrating Consistent Sotagliflozin Results Across Baseline Blood Pressure Levels in Patients with Recent Worsening Heart Failure
31/08/2026
Findings presented at ESC Congress 2026 and simultaneously published in JACC: Heart Failure THE WOODLANDS, Texas, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced results [...]
Allogene Therapeutics Announces Participation in September Investor Conference
31/08/2026
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for [...]

Pages